| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
Sarin, Shiv
|
|
|
18 |
2 |
p. 708-815
|
artikel
|
| 2 |
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma
|
Tang, Shi-Chuan
|
|
|
18 |
2 |
p. 623-635
|
artikel
|
| 3 |
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
|
Yu, Ming-Lung
|
|
|
18 |
2 |
p. 461-475
|
artikel
|
| 4 |
Artificial intelligence in liver imaging: methods and applications
|
Zhang, Peng
|
|
|
18 |
2 |
p. 422-434
|
artikel
|
| 5 |
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
|
Kim, Dong-Sik
|
|
|
18 |
2 |
p. 299-383
|
artikel
|
| 6 |
Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease
|
Ganesan, Raja
|
|
|
18 |
2 |
p. 486-499
|
artikel
|
| 7 |
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
|
Mao, Yimin
|
|
|
18 |
2 |
p. 384-419
|
artikel
|
| 8 |
ChIP-seq analysis found IL21R, a target gene of GTF2I–the susceptibility gene for primary biliary cholangitis in Chinese Han
|
Wu, Ziyan
|
|
|
18 |
2 |
p. 509-516
|
artikel
|
| 9 |
Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
|
Wang, Yan
|
|
|
18 |
2 |
p. 702-703
|
artikel
|
| 10 |
Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population
|
Xu, Yurou
|
|
|
18 |
2 |
p. 529-539
|
artikel
|
| 11 |
Diagnostic yield and novel candidate genes by next generation sequencing in 166 children with intrahepatic cholestasis
|
Zheng, Yucan
|
|
|
18 |
2 |
p. 661-672
|
artikel
|
| 12 |
Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity
|
Cheng, Xue
|
|
|
18 |
2 |
p. 582-594
|
artikel
|
| 13 |
Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply
|
Pfisterer, N.
|
|
|
18 |
2 |
p. 706-707
|
artikel
|
| 14 |
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma
|
Suzuki, Hiroyuki
|
|
|
18 |
2 |
p. 610-622
|
artikel
|
| 15 |
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B
|
Zhang, Min
|
|
|
18 |
2 |
p. 435-448
|
artikel
|
| 16 |
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
|
Santagata, Sara
|
|
|
18 |
2 |
p. 568-581
|
artikel
|
| 17 |
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study
|
Huang, Daniel Q.
|
|
|
18 |
2 |
p. 540-549
|
artikel
|
| 18 |
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated
|
Li, Sai
|
|
|
18 |
2 |
p. 704-705
|
artikel
|
| 19 |
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32
|
Kim, Tae Hyung
|
|
|
18 |
2 |
p. 500-508
|
artikel
|
| 20 |
Nomograms should be noted
|
Obi, Shuntaro
|
|
|
18 |
2 |
p. 420-421
|
artikel
|
| 21 |
OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma
|
Tan, Juntao
|
|
|
18 |
2 |
p. 550-567
|
artikel
|
| 22 |
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age–period–cohort model for estimating demand from antecedent anti-HCV survey
|
Lin, Ting-Yu
|
|
|
18 |
2 |
p. 476-485
|
artikel
|
| 23 |
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
|
Kamiliou, Aikaterini
|
|
|
18 |
2 |
p. 688-699
|
artikel
|
| 24 |
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan
|
Hsu, Chao-Wei
|
|
|
18 |
2 |
p. 449-460
|
artikel
|
| 25 |
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis
|
Chen, Lanlan
|
|
|
18 |
2 |
p. 517-528
|
artikel
|
| 26 |
Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
|
Park, Jin Wook
|
|
|
18 |
2 |
p. 700-701
|
artikel
|
| 27 |
Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China
|
Zeng, Xin
|
|
|
18 |
2 |
p. 673-687
|
artikel
|
| 28 |
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis
|
Liu, Jiaxi
|
|
|
18 |
2 |
p. 595-609
|
artikel
|
| 29 |
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors
|
Zeng, Zhen-Xin
|
|
|
18 |
2 |
p. 651-660
|
artikel
|
| 30 |
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
|
Wang, Fu
|
|
|
18 |
2 |
p. 636-650
|
artikel
|
Tijdschrift beschrijving